- Earlier this year, the U.S. Food and Drug Administration (FDA) released the draft and final guidance topics that are a priority for the agency’s Foods Program to complete during 2024. FDA has since issued the following guidances from that list:
- New Dietary Ingredient (NDI) Notifications and Related Issues: NDI Notification Procedures and Timeframes: Guidance for Industry
- New Dietary Ingredient Notification Master Files for Dietary Supplements; Draft Guidance for Industry
- Foods Derived from Plants Produced Using Genome Editing; Guidance for Industry
- Recommendations for Collecting Representative Samples for Food Testing Used as Evidence for Release of Certain Fish and Fishery Products Subject to Detention Without Physical Examination (DWPE) and Removal of a Foreign Manufacturer’s Goods from DWPE: Guidance for Industry
- Hazard Analysis and Risk-Based Preventive Controls for Human Food; Appendix 1: Potential Hazards for Foods and Processes; Draft Guidance for Industry
- While these guidances are not legally enforceable, they represent the FDA’s current thinking on specific topics and allow stakeholders to plan for potential changes that may impact them. Interested parties may submit public comments on the list of human food and cosmetic guidance topics, including suggestions for alternatives or recommendations on the topics the FDA is considering.
- The guidance documents that have been issued so far in 2024 have been removed, and an updated list can be found at Foods Program Guidance Under Development.